Suspension of license pharma firm:DCGI
The DCGI now suspends the license of the Parenteral Surgical India Pvt Ltd. after using the contaminated IV fluids at Jodhpur hospitals.
Say something
The DCGI now suspends the license of the Parenteral Surgical India Pvt Ltd. after using the contaminated IV fluids at Jodhpur hospitals.
Bristol-Myers Squibb now collaborates with the much established WuXi PharmaTech.
A team of Dutch scientists at the Statens Serum Institute in Copenhagen, an effective vaccine to fight tuberculosis (TB) before and after infection has developed.
Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.
Google and Microsoft have partnered with the US administration to establish a not-for-profit organisation aimed at blocking illegal online pharmacies from selling counterfeit prescription drugs.
The scientists from Eastern Virginia Medical School have identified a potential novel treatment strategy for the social impairment of people with Autism Spectrum Disorders (ASD).
The Pharmaceuctical Group of the European Union (PGEU) the association representing Community Pharmacists, calls for pharmacists to be granted access to electronic patient records in a statement on E Health released.
An indigenous vaccine will help rid Africa of meningitis, one of the continent’s worst enemies.
The sale of anti-obesity medicine Sibutramine has been banned in India due to rising instances of heart attacks among its users, the Drugs Controller General of India (DCGI) revealed.
The global initiative to eradicate polio could provide net benefits of at least US $40-50 billion if transmission of wild polioviruses is interrupted within the next five years, according to a new study.
The Mumbai-based firm has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) to market a generic version of Schering Plough’s Clarinex tablets, Sun Pharma said in a statement.
Even as the health ministry drags its feet over a national antibiotic policy, the Central Drugs Standard Control Organisation has prepared draft notifications that will regulate antibiotic drugs and the treatment of infectious diseases.